Autophagy, Apoptosis, Mitoptosis and Necrosis: Interdependence Between Those Pathways and Effects on Cancer

• Published in: Archivum Immunologiae et Therapiae Experimentalis Vol. 61; no. 1; pp. 43 - 58
• Main Authors: Chaabane, Wiem, User, Sırma D., El-Gazzah, Mohamed, Jaksik, Roman, Sajjadi, Elaheh, Rzeszowska-Wolny, Joanna, Łos, Marek J.
• Format: Journal Article
• Language: English
• Published: Basel SP Birkhäuser Verlag Basel 01.02.2013; Springer Nature B.V
• Subjects: Animals; Apoptosis; Autophagy; Biomedical and Life Sciences; Biomedicine; Humans; Immunology; Mitochondria - metabolism; Necrosis; Neoplasms - metabolism; Neoplasms - pathology; Pharmacology/Toxicology; Review; Signal Transduction; Mitochondria; Hsp-70; RIPK; PKC-delta; Mdm2; mTOR; AMPK; VHL; PARP-1; TNF
• ISSN: 0004-069X; 1661-4917; 1661-4917
• DOI: 10.1007/s00005-012-0205-y

Cell death is a fundamental ingredient of life. Thus, not surprisingly more than one form of cell death exists. Several excellent reviews on various forms of cell death have already been published but manuscripts describing interconnection and interdependence between such processes are uncommon. Here, what follows is a brief introduction on all three classical forms of cell death, followed by a more detailed insight into the role of p53, the master regulator of apoptosis, and other forms of cell death. While discussing p53 and also the role of caspases in cell death forms, we offer insight into the interplay between autophagy and apoptosis, or necrosis, where autophagy may initially serve pro-survival functions. The review moves further to present some details about less researched forms of programmed cell death, namely necroptosis, necrosis and mitoptosis. These “mixed” forms of cell death allow us to highlight the interconnected nature of cell death forms, particularly apoptosis and necrosis. The interdependence between apoptosis, autophagy and necrosis, and their significance for cancer development and treatment are also analyzed in further parts of the review. In the concluding parts, the afore-mentioned issues will be put in perspective for the development of novel anti-cancer therapies.